| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f66582b660942080bc6df4991521dc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c99fc850018b882e64a1a8e25a4a808a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6587a416cc1ab9e35c4aab3d9074ee0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a08e2195b3df456a4567304dbd6eba01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2014-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_768555d4f24dc55eb324f3c7b4f54c95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cb4516e4f31b1ee94af66561a376194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ffb89e4daddcaebfd908520e45f8a51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab677dc68ed9b829cf4d4ad3f5a96632
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c42a47dbb733669e29b11b25bb1c18c1 |
| publicationDate |
2018-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9902709-B2 |
| titleOfInvention |
Polysubstituted pyridine compound, preparation method, use and pharmaceutical composition |
| abstract |
The present invention provides a polysubstituted pyridine compound of Formula I, a preparation method, a use and a pharmaceutical composition thereof. The polysubstituted pyridine compound of Formula I according to the present invention has an excellent anti-tumor effect, can inhibit various cell kinases simultaneously, has significantly excellent pharmacokinetic characteristics, and is very suitable for oral and intravenous administration. The pharmaceutical composition according to the present invention can be useful for treating tumors and cancers. |
| priorityDate |
2014-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |